Diamel

Asset

Stage
Phase 3, no development reported
Modality
Supplement
Target
Not known
2
Indications
36
Trials
1
Developer

No development reported since April 2012. Last activity: Trial NCT00820651 completed. clinicaltrials.gov

Indications

2

In the full profile

  • Target and mechanism2
  • Owner and partners1
  • Trials36
  • Evidence for its targets2
  • Competitors12
  • Signals15

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets